Imagine a device that could deliver perfectly targeted chemotherapy drugs to the area of the brain affected by a brain tumor, or a form of systemically injected gene therapy that could be used to treat Alzheimer's disease or autism. Consider a less invasive way of treating a brain aneurism. Or think of an implanted device that could detect the origin of an epileptic seizure.
These were just a few of the ideas on the table when Weill Cornell Medical College neurosurgeons traveled from New York City to Ithaca to meet with their colleagues in Cornell's Department of Biomedical Engineering on July 20 and 21.
Biomedical Engineering Treat Wrap up
